MrsYan Whisler
ASO PROF
PH-PHARMTHERAPY TRNSL RSCH
GRANTS
- GRANTCardioprotection and Risk Determinants in Cancer Patients with Immune Checkpoint Inhibitor TherapyAmerican Heart Association1 Jan 2026 - 31 Dec 2027
- GRANTCardiovascular Adverse Events Related to Aromatase Inhibitors in Breast CancerFlorida Breast Cancer Foundation18 Jul 2024 - 30 Jun 2026
- GRANTCardiovascular Adverse Events Related to Aromatase Inhibitors in Female Breast CancerNational Institute of Health1 Mar 2024 - 31 Aug 2024
- GRANTToward a Precision Medicine Approach to Medication-Related Osteonecrosis of the JawNational Institute of Health Nidcr7 Sep 2021 - 6 Sep 2023
- GRANTReplication of GenHAT GWAS signals in Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) and Genetic Epidemiology of Responses to Antihypertensives (GERA)National Institute of Health6 Aug 2021 - 31 Aug 2021
- GRANTA Multi-omics evaluation of Carfilzomib-related CardiotoxicityNational Institute of Health Nhlbi12 Jul 2021 - 31 Jul 2026
- GRANTPrecision antiplatelet therapy after percutaneous coronary interventionNational Institute of Health Nhlbi15 Jun 2020 - 30 Jun 2026
- GRANTPharmacokinetics of Anti-tuberculosis and Antiretroviral Drugs in ChildrenNational Institute of Health Nichd24 Aug 2018 - 31 Aug 2025
- GRANTCarboxylesterase 1 Genetic Variation and Methylphenidate in ADHDNational Institute of Health Nichd16 Aug 2018 - 31 Jul 2025
- GRANTPharmacokinetics of Anti-tuberculosis and Antiretroviral Drugs in ChildrenNational Institute of Health Nichd1 Jun 2016 - 31 Aug 2018
- GRANTOneFlorida Clinical Research Consortium Phase IIPatient-Centered Outcomes Research Institute8 Dec 2015 - 29 Mar 2019